Trials / Completed
CompletedNCT05049980
Patient Satisfaction With the Management of a Stopped Pregnancy in the First Trimester
Evaluation of the Efficacy, Tolerance of the Treatment, and Patient Satisfaction During the Management of an Arrested Pregnancy in the First Trimester According to the New Toulouse University Hospital Protocol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- Female
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The clinical practice recommendations highlight the fact that the patient's choice concerning the management of her aborted pregnancy in the first trimester should be privileged, after clear and appropriate information on the available treatments, in order to improve his experience and reduce the negative psychological symptoms that can generate an alteration in the quality of life, in the aftermath of the loss of pregnancy. The present study will describe the efficacy, satisfaction and tolerance of patients benefiting from medical treatment with Mifégyne® and MisoOne® versus those benefiting from surgical treatment by endo-uterine aspiration for the management of a pregnancy stopped during the first trimester at the Toulouse University Hospital
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Medical treatment with Mifégyne® and MisoOne® | When participants arrive for their uterine emptiness check-up, 12 days after treatment, patients will be asked to drop off the study questionnaire the same day in a box provided for this purpose in the department. |
| PROCEDURE | Endo-uterine aspiration | When patients arrive in hospital on the day of the surgery, participants will be asked to complete a questionnaire at home 1 week after surgery and return it to investigators. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-02-14
- Completion
- 2022-02-14
- First posted
- 2021-09-20
- Last updated
- 2022-03-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05049980. Inclusion in this directory is not an endorsement.